Eli Lilly Europe — Revenue decreased by 11.5% to $3.10B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 26.5%, from $2.45B to $3.10B. Over 4 years (FY 2021 to FY 2025), Europe — Revenue shows an upward trend with a 24.7% CAGR.
lly_segment_europe_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.21B | $1.10B | $1.15B | $1.07B | $1.10B | $1.06B | $1.07B | $1.09B | $1.18B | $2.57B | $1.34B | $1.44B | $1.40B | $1.63B | $2.45B | $2.39B | $2.57B | $3.50B | $3.10B |
| QoQ Change | — | -9.2% | +4.4% | -7.0% | +3.2% | -4.1% | +1.7% | +1.5% | +7.9% | +118.1% | -47.9% | +7.7% | -2.6% | +16.0% | +50.3% | -2.4% | +7.8% | +35.9% | -11.5% |
| YoY Change | — | — | — | — | -9.0% | -3.8% | -6.3% | +2.2% | +6.9% | +143.1% | +24.5% | +32.1% | +19.2% | -36.6% | +83.0% | +65.8% | +83.4% | +114.8% | +26.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.